1. Home
  2. ZNTL vs IPI Comparison

ZNTL vs IPI Comparison

Compare ZNTL & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZNTL
  • IPI
  • Stock Information
  • Founded
  • ZNTL 2014
  • IPI 2000
  • Country
  • ZNTL United States
  • IPI United States
  • Employees
  • ZNTL N/A
  • IPI N/A
  • Industry
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • ZNTL Health Care
  • IPI Industrials
  • Exchange
  • ZNTL Nasdaq
  • IPI Nasdaq
  • Market Cap
  • ZNTL 300.4M
  • IPI 309.4M
  • IPO Year
  • ZNTL 2020
  • IPI 2008
  • Fundamental
  • Price
  • ZNTL $3.93
  • IPI $25.15
  • Analyst Decision
  • ZNTL Buy
  • IPI Hold
  • Analyst Count
  • ZNTL 7
  • IPI 1
  • Target Price
  • ZNTL $13.14
  • IPI $23.00
  • AVG Volume (30 Days)
  • ZNTL 3.0M
  • IPI 72.1K
  • Earning Date
  • ZNTL 08-07-2024
  • IPI 07-31-2024
  • Dividend Yield
  • ZNTL N/A
  • IPI N/A
  • EPS Growth
  • ZNTL N/A
  • IPI N/A
  • EPS
  • ZNTL N/A
  • IPI N/A
  • Revenue
  • ZNTL $40,560,000.00
  • IPI $271,450,000.00
  • Revenue This Year
  • ZNTL N/A
  • IPI N/A
  • Revenue Next Year
  • ZNTL N/A
  • IPI $4.92
  • P/E Ratio
  • ZNTL N/A
  • IPI N/A
  • Revenue Growth
  • ZNTL N/A
  • IPI N/A
  • 52 Week Low
  • ZNTL $3.27
  • IPI $17.52
  • 52 Week High
  • ZNTL $29.03
  • IPI $28.30
  • Technical
  • Relative Strength Index (RSI)
  • ZNTL 34.44
  • IPI 64.16
  • Support Level
  • ZNTL $3.83
  • IPI $24.23
  • Resistance Level
  • ZNTL $4.79
  • IPI $26.39
  • Average True Range (ATR)
  • ZNTL 0.41
  • IPI 0.72
  • MACD
  • ZNTL 0.31
  • IPI 0.33
  • Stochastic Oscillator
  • ZNTL 67.76
  • IPI 83.87

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

Share on Social Networks: